Leishmanicidal Effects of Piperlongumine (Piplartine) and Its Putative Metabolites

Fernanda de Lima Moreira; Thalita Bachelli Riul; Marcela de Lima Moreira; Alan Cesar Pilon; Marcelo Dias-Baruffi; Márcio S. S. Araújo; Norberto Peporine Lopes; Anderson R. M. de Oliveira

doi:10.1055/a-0614-2680

Planta Medica, Table of Contents

Planta Med 2018; 84(15): 1141-1148
DOI: 10.1055/a-0614-2680

Natural Product Chemistry and Analytical Studies

Original Papers

Georg Thieme Verlag KG Stuttgart · New York

Leishmanicidal Effects of Piperlongumine (Piplartine) and Its Putative Metabolites

Fernanda de Lima Moreira

¹Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto – SP, Brazil

,

Thalita Bachelli Riul

²Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto – SP, Brazil

,

Marcela de Lima Moreira

³Instituto René Rachou, Fundação Oswaldo Cruz – FIOCRUZ/MG, Belo Horizonte – MG, Brazil

,

Alan Cesar Pilon

⁴Núcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS), Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto –SP, Brazil

,

Marcelo Dias-Baruffi

²Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto – SP, Brazil

,

Márcio S. S. Araújo

³Instituto René Rachou, Fundação Oswaldo Cruz – FIOCRUZ/MG, Belo Horizonte – MG, Brazil

,

Norberto Peporine Lopes

⁴Núcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS), Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto –SP, Brazil

,

Anderson R. M. de Oliveira

⁵Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto – SP, Brazil

› Author Affiliations

Abstract

Piperlongumine is an amide alkaloid found in Piperaceae species that shows a broad spectrum of biological properties, including antitumor and antiparasitic activities. Herein, the leishmanicidal effect of piperlongumine and its derivatives produced by a biomimetic model using metalloporphyrins was investigated. The results showed that IC₅₀ values of piperlongumine in promastigote forms of Leishmania infantum and Leishmania amazonensis were 7.9 and 3.3 µM, respectively. The IC₅₀ value of piperlongumine in the intracellular amastigote form of L. amazonensis was 0.4 µM, with a selectivity index of 25. The piperlongumine biomimetic derivatives, Ma and Mb, also showed leishmanicidal effects. We also carried out an in vitro metabolic degradation study showing that Ma is the most stable piperlongumine derivative in rat liver microsome incubations. The results presented here indicate that piperlongumine is a potential leishmanicidal candidate and support the biomimetic approach for development of new antileishmanial derivatives.

Key words

cyclic amides - piplartine - metalloporphyrin - leishmaniasis - selectivity index - piperlongumine - Piperaceae - analogues

Full Text

References

References
1 Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer M. The WHO leishmaniasis control team, 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7: e35671
2 World Health Organization. WHO to implement online epidemiological surveillance for leishmaniasis, 2016. Available at: http://www.who.int/neglected_diseases/news/WHO_implement_epidemiological_surveillance_leishmaniasis/en/ Accessed August 24, 2016
3 Cota GF, Sousa MR, Mendonça ALP, Patrocinio A, Assunção LS, Faria SR, Rabello A. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in brazil. PLoS Neglected Trop Dis 2014; 8: e2816
4 Elmahallawy EK, Agil A. Treatment of leishmaniasis: a review and assessment of recent research. Curr Pharm Des 2015; 21: 2259-2275
5 de Menezes JPB, Guedes CES, Petersen ALOA, Fraga DBM, Veras PST. Advances in development of new treatment for leishmaniasis. Biomed Res Intern 2015; 2015: 815023
6 Balasegaram M, Ritmeijer K, Lima MA, Burza S, Genovese GO, Milani B, Gaspani S, Potet J, Chappuis F. Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin Emerging Drugs 2012; 17: 493-510
7 Cheuka PM, Mayoka G, Mutai P, Chibale K. The role of natural products in drug discovery and development against neglected tropical diseases. Molecules 2017; 22: e58
8 Ndjonka D, Rapado LN, Silber AM, Liebau E, Wrenger C. Natural products as a source for treating neglected parasitic diseases. Int J Mol Sci 2013; 14: 3395-3439
9 Gutierrez RMP, Gonzalez AMN, Hoyo-Vadillo C. Alkaloids from Piper: a review of its phytochemistry and pharmacology. Mini Rev Med Chem 2013; 13: 163-193
10 Mgbeahuruike EE, Yrjönen T, Vuorela H, Holm Y. Bioactive compounds from medicinal plants: Focus on Piper species. S Afr J Chem Botany 2017; 112: 54-69
11 Zheng J, Son DJ, Gu SM, Woo JR, Ham YW, Lee HP, Kim WJ, Jung JK, Hong JT. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway. Sci Rep 2016; 6: 26357
12 Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Adam A, Torres D, Zhang X, Dobrolecki LE, Wei W, Lewis MT, Dave B, Chang JC, Landis MD, Creighton CJ, Mancini MA, Tweardy DJ. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene 2015; 34: 1341-1353
13 Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. Overview of the therapeutic potential of piplartine (PPL). Eur J Pharm Sci 2013; 48: 453-463
14 Raj L, Ide T, Gurkar AU, Foley M, Scenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011; 475: 231-234
15 Araújo-Vilges KM, Oliveira SV, Couto SCP, Fokoue HH, Romero GAS, Kato MJ, Romeiro LAS, Leite JRSA, Kuckelhaus SAS. Effect of piplartine and cinnamides on Leishmania amazonensis, Plasmodium falciparum and on peritoneal cells of Swiss mice. Pharm Biol 2017; 55: 1601-1607
16 Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Schistosoma mansoni schistosomula and adult worms. Curr Med Chem 2013; 20: 301-309
17 Moraes Jd. Nascimento C, Lopes PO, Nakano E, Yamaguchi LF, Kato MJ, Kawano T. Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp Parasitol 2011; 127: 357-364
18 Bodiwala HS, Singh G, Singh CS, Dey SS, Sharma KK, Bhutani IP. Antileishmanial amides and lignans from Piper cubeba and Piper retroforactum . Nat Med 2007; 61: 418-421
19 Wang YH, Wang LT, Hsieh KY, Natschke SL, Tang GH, Long CL, Lee KH. Multidrug resistance-selective antiproliferative activity of Piper amide alkaloids and synthetic analogues. Bioorg Med Chem Lett 2014; 24: 4818-4821
20 Sun LD, Wang F, Dai F, Wang YH, Lin D, Zhou B. Development and mechanism investigation of a new PPL derivative as a potent anti-inflammatory agent. Biochem Pharmacol 2015; 95: 156-169
21 Cusack KP, Koolman HF, Lange UEW, Peltier HM, Piel I, Vasudevan A. Emerging technologies for metabolite generation and structural diversification. Bioorg Med Chem Lett 2015; 23: 5471-5483
22 Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol 2008; 21: 70-83
23 Moreira FL, Habenschus M, Barth T, Marques LMM, Pilon AC, Bolzani VS, Vessecchi R, Lopes NP, Oliveira ARM. Metabolic profile and safety of piperlongumine. Sci Rep 2016; 6: 33646
24 Marques LMM, da Silva jr. EA, Gouvea DR, Vessecchi R, Pupo MT, Lopes NP, Kato MJ, de Oliveira AR. In vitro metabolism of the alkaloid piplartine by rat liver microsomes. J Pharm Biomed Anal 2014; 95: 113-120
25 Bauermeister A, Aguiar FA, Marques LMM, Malta-Júnior JS, Barros F, Callejon DR, Oliveira ARM, Lopes NP. In vitro metabolism evaluation of the ergot alkaloid dihydroergotamine: application of microsomal and biomimetic oxidative model. Planta Med 2016; 82: 1368-1373
26 Niehues M, Barros VP, Emery FS, Dias-Baruffi M, Assis MD, Lopes NP. Biomimetic in vitro oxidation of lapachol: a model to predict and analyse the in vivo phase I metabolism of bioactive compounds. Eur J Med Chem 2012; 54: 804-812
27 Adams DJ, Dai M, Pellegrino G, Wagner BK, Stern AM, Shamji AF, Schreiber SL. Synthesis, cellular evaluation, and mechanism of action of PPL analogs. Proc Natl Acad Sci U S A 2012; 109: 15115-15120
28 Don R, Ioset JR. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections. Parasitology 2014; 141: 140-146
29 Pink R, Hudson A, Mouries MA, Bendig M. Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 2005; 4: 727-740
30 Liu JM, Pan F, Li L, Liu QR, Chen Y, Xiong XX, Cheng K, Yu SB, Yu ACH, Chen XQ. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 2013; 436: 87-93
31 Fonseca-Silva F, Inacio JDF, Canto-Cavalheiro MM, Menna-Barreto RFS, Almeida-Amaral EE. Oral efficacy of apigenin against cutaneous leishmaniasis: involvement of reactive oxygen species and autophagy as a mechanism of action. PLoS Negl Trop Dis 2016; 10: e0004442
32 Fonseca-Silva F, Inacio JDF, Canto-Cavalheiro MM, Almeida-Amaral EE. Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes. J Nat Prod 2013; 76: 1505-1508
33 Katsuno K, Burrows JN, Duncan K, Huijsduijnen RH, Kaneko T, Kita K, Mowbray CE, Schmatz D, Warner P, Slingsby BT. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov 2015; 14: 751-758
34 Sharefkin JG, Saltzman H. Organic Syntheses Collective. Organic Syntheses, Inc 1973; 5: 660
35 Lucas HJ, Kenedy ER, Forno MW. Organic Syntheses Collective. Organic Syntheses, Inc 1963; 43: 62

Supplementary Material

Supporting Information